BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5093948)

  • 1. Tumour sensitivity to cytembena in women with metastasizing gynaecological carcinoma in relation to certain inherited blood characters and serum isoenzymes.
    Milunicová A; Jandová A; Skoda V
    Neoplasma; 1971; 18(3):289-98. PubMed ID: 5093948
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of some inherited blood characters, changes in fifth fraction of serum lactate dehydrogenase, and resistance to cytembena in women with gynaecological carcinoma.
    Milunicová A; Jandová A; Skoda V
    Neoplasma; 1971; 18(2):219-24. PubMed ID: 5577318
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytembena treatment of advanced gynaecological carcinomas.
    Dvorák O
    Neoplasma; 1971; 18(5):461-4. PubMed ID: 5119520
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term administration of cytembena and cyclophosphamide to patients with gynaecological carcinoma. (Evaluation ff laboratory examinations).
    Jandová A; Skoda V; Novotná J; Pezlarová I; Pick P
    Neoplasma; 1971; 18(2):197-218. PubMed ID: 5280733
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum enzyme during endoxan treatment].
    Dacić Z
    Med Klin; 1966 Apr; 61(16):642-4. PubMed ID: 5988317
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary ability to taste PTC, activity of LDH, LDH5 AF, GOT and GPT in patients with carcinoma of the uterus.
    Jandová A; Milunicová A; Novotná J; Skoda V; Laurová L
    Neoplasma; 1970; 17(2):169-73. PubMed ID: 5425394
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymes and isoenzymes in different body tissue and fluids in benign and malignant gynecological tumors.
    Menaché R; Rubinstein I; Israel S; Halbrecht I
    Isr J Med Sci; 1977 Aug; 13(8):848-51. PubMed ID: 893068
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of Cytembena in the treatment of malignant musculoskeletal tumours.
    Matĕjovský Z
    Neoplasma; 1971; 18(5):473-80. PubMed ID: 4330363
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R
    Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytembena treatment of advances and relapsing uterine cervix carcinoma.
    Dvorák O; Bauer J
    Neoplasma; 1971; 18(5):465-6. PubMed ID: 5119521
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum enzyme studies during intra-arterial Trenimon therapy of genital carcinoma].
    Daccić Z
    Med Welt; 1967 May; 18():1148-51. PubMed ID: 5634311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of lactic acid isoenzyme (LDH5) in the serum during the cytostatic treatment of gynecologic cancer].
    Skoda V; Trnková M; Skramovský V; Jandová A; Novotná J
    Cesk Gynekol; 1967 Feb; 32(1):14-7. PubMed ID: 6044942
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the behavior of serum enzymes LDH, GOT and GPT in tumors and the possibility of diagnostic and prognostic conclusions].
    Buchelt L; Hess F
    Strahlentherapie; 1968 Nov; 136(5):574-80. PubMed ID: 5708883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

  • 17. Hereditary blood and serum types, PTC test and level of the fifth fraction of serum lactatedehydrogenase in females with gynecological cancer. II. (Communication).
    Milunicová A; Jandová A; Laurová L; Novotná J; Skoda V
    Neoplasma; 1969 Jun; 16(3):311-6. PubMed ID: 4981696
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alkaline phosphatase and transaminases in serum during irradiation of genital carcinoma in women].
    Engelhardt W; Penning W
    Munch Med Wochenschr; 1972 Nov; 114(44):1914-6. PubMed ID: 4678728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enzyme studies during endolymphatic 131-I-lipiodol instillation].
    Janisch H; Michalica W; Picha E; Simanyi M
    Geburtshilfe Frauenheilkd; 1971 Aug; 31(8):768-72. PubMed ID: 4328284
    [No Abstract]   [Full Text] [Related]  

  • 20. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities.
    Boutselis JG; Ullery JC; Pace W
    Ohio State Med J; 1971 Aug; 67(8):721-5. PubMed ID: 4105456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.